Cantor Fitzgerald Reiterates a 'Sell' on Ironwood Pharmaceuticals (IRWD); Shares Still Overvalued

Go back to Cantor Fitzgerald Reiterates a 'Sell' on Ironwood Pharmaceuticals (IRWD); Shares Still Overvalued

Ironwood Pharma (IRWD) Resumes 3.6% Lower, Moves Higher

August 30, 2012 2:22 PM EDT

Ironwood Pharmaceuticals (Nasdaq: IRWD) resumes trading, down 3.6 percent but moving higher.... More